Le Lézard
Classified in: Oil industry, Health
Subject: LAW

Mesothelioma Compensation Center Now Offers Direct Access to Erik Karst of the Law Firm Karst & von Oiste for an Oil Refinery Worker with Mesothelioma or Asbestos Exposure Lung Cancer Seeking the Best Compensation


NEW YORK, Jan. 9, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We are the top branded source in the nation when it comes to financial compensation for an oil refinery worker who has confirmed mesothelioma or asbestos exposure lung cancer. We are urging a current or former oil refinery worker in any state who is dealing with a recent mesothelioma or asbestos exposure lung cancer diagnosis to call us anytime at 800-714-0303 so we can explain why it is so incredibly important to talk to an extremely skilled-full time mesothelioma attorney like our recommend attorney-Erik Karst.

"If you have mesothelioma or asbestos exposure lung cancer and you fail to retain the services of one of the nation's most qualified attorneys, there is a very good chance you will not be properly compensated. When we mention not getting 'properly compensated' we are referring to hundreds of thousands of dollars or more in financial compensation that a person with mesothelioma or asbestos exposure lung cancer potentially will never see." http://MesotheliomaCompensationCenter.Com

The Mesothelioma Compensation Center also wants to emphasize that once a person with mesothelioma hires a law firm for a mesothelioma compensation claim, they are stuck with that firm. The group has endorsed the law firm of Karst & von Oiste because these are extremely capable and skilled lawyers will do everything possible to ensure their clients receive the best possible financial compensation-nationwide.

As the Mesothelioma Compensation Center would like to discuss anytime, "We are urging a oil refinery or oil/gas production worker with mesothelioma or asbestos exposure lung cancer to call us anytime at 800-714-0303 so at a minimum we introduce you to Erik Karst one of the founding partners of Karst & von Oiste and one of the most passionate attorneys we have ever met when it comes to power or energy workers receiving the very best financial compensation if they have mesothelioma or asbestos exposure lung cancer."  www.karstvonoiste.com/

The Mesothelioma Compensation Center is especially focused on assisting oil refinery workers with mesothelioma in any US State including:

For an interactive map of all US oil refineries please review the following website: http:// refineryreport.org/refineries. php.

About the amazing law firm of Karst & von Oiste for people nationwide with mesothelioma or asbestos exposure lung cancer: Karst von Oiste is a national law firm, dedicated to helping asbestos exposure victims and their families pursue financial compensation. They are a proven leader in lawsuits involving exposure to asbestos. They have a long history of achieving substantial verdicts and settlements for their clients who are suffering from Mesothelioma and Asbestos-related cancer. www.karstvonoiste.com/

According to the CDC the states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. However, an oil refinery worker with mesothelioma could live in any state including California, New York, Florida, Texas, Illinois, Kentucky, Tennessee, Georgia, Alabama, Nebraska, South Dakota, North Dakota, Wyoming, Colorado, Nevada, New Mexico, Arizona, Idaho, or Alaska. 
http:// MesotheliomaCompensationCenter.Com

The Mesothelioma Compensation Center specializes in assisting high-risk workers who have been diagnosed with mesothelioma. High-risk groups for exposure to asbestos include the US Navy Veterans, power plant workers, shipyard workers, oil refinery workers, public utility workers, chemical plant workers, nuclear power plant workers, oil and gas field production workers, hydro-electric workers, plumbers, electricians, welders, millwrights, pipefitters or machinists. In most instances people with mesothelioma were exposed to asbestos in the 1950's, 1960's, 1970's, or 1980's as the group would like to discuss anytime at 800-714-0303.

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer: https://www.cancer. gov/types/mesothelioma.

Contact:
Michael Thomas
800-714-0303
[email protected]

SOURCE Mesothelioma Compensation Center


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: